We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-1.13%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$103B
AUM Growth
+$1.83B
Cap. Flow
+$3.67B
Cap. Flow %
3.57%
Top 10 Hldgs %
46.02%
Holding
3,718
New
534
Increased
1,981
Reduced
979
Closed
136

Sector Composition

Rank Sector Weight
1 Technology 7.11%
2 Financials 3.31%
3 Consumer Discretionary 2.07%
4 Healthcare 1.66%
5 Communication Services 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLH icon
3226
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
$59.4K ﹤0.01%
+597
New +$61.8K
AMBP icon
3227
Ardagh Metal Packaging
AMBP
$2.96B
$58.2K ﹤0.01%
19,344
-19,422
-50% -$69.9K
ORGO icon
3228
Organogenesis Holdings
ORGO
$324M
$57.7K ﹤0.01%
18,033
-2,469
-12% -$8.28K
OGIG icon
3229
ALPS O'Shares Global Internet Giants ETF
OGIG
$102M
$57.4K ﹤0.01%
+1,247
New +$56.6K
SFIX
3230
Stitch Fix
SFIX
$567M
$57.1K ﹤0.01%
13,243
-12,234
-48% -$45.1K
ERAS icon
3231
Erasca
ERAS
$6.15B
$56.9K ﹤0.01%
22,684
+2,670
+13% +$7.32K
IAG icon
3232
IAMGOLD
IAG
$8.05B
$56.8K ﹤0.01%
11,017
+115
+1% +$615
GNSS icon
3233
Genasys
GNSS
$76.5M
$56.7K ﹤0.01%
21,794
+244
+1% +$856
KRMD icon
3234
KORU Medical Systems
KRMD
$187M
$56.5K ﹤0.01%
14,667
USIO icon
3235
Usio Inc
USIO
$54.4M
$56.2K ﹤0.01%
38,508
-4,226
-10% -$5.99K
HYLN icon
3236
Hyliion Holdings
HYLN
$578M
$55.1K ﹤0.01%
21,117
+9,313
+79% +$25.9K
WTI icon
3237
W&T Offshore
WTI
$525M
$54.5K ﹤0.01%
32,841
-253,906
-89% -$507K
MRKR icon
3238
Marker Therapeutics
MRKR
$18.5M
$53.8K ﹤0.01%
17,312
HOOD icon
3239
PUT
Robinhood
HOOD
$80.7B
$53.6K ﹤0.01%
+10,400
New +$336K
ANVS icon
3240
Annovis Bio
ANVS
$72.3M
$52.6K ﹤0.01%
+10,460
New +$75.7K
SSP icon
3241
E.W. Scripps
SSP
$270M
$52.5K ﹤0.01%
23,762
+267
+1% +$617
EPM icon
3242
Evolution Petroleum
EPM
$133M
$52.3K ﹤0.01%
10,000
WVVI icon
3243
Willamette Valley Vineyards
WVVI
$12.7M
$52.3K ﹤0.01%
15,600
RVNC
3244
DELISTED
Revance Therapeutics, Inc.
RVNC
$52.1K ﹤0.01%
17,136
+6,278
+58% +$27.3K
GEVO icon
3245
Gevo
GEVO
$353M
$52K ﹤0.01%
24,880
+4,138
+20% +$7.84K
AIRS icon
3246
AirSculpt Technologies
AIRS
$308M
$51.9K ﹤0.01%
10,000
DH icon
3247
Definitive Healthcare
DH
$77M
$51.8K ﹤0.01%
+12,615
New +$55.2K
NGD
3248
DELISTED
New Gold Inc
NGD
$51.8K ﹤0.01%
20,904
+324
+2% +$894
TVGN icon
3249
Tevogen Bio Holdings
TVGN
$25.1M
$51.5K ﹤0.01%
+1,000
New +$65.2K
GGN
3250
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$762M
$50.6K ﹤0.01%
13,413

Similar funds

Creative Planning's Q4 2024 Portfolio in Review

As of Q4 2024, Creative Planning held 3,718 positions worth $103B, up 1.8% from $101B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Creative Planning deployed $3.67B of net new capital in Q4 2024, opening 534 new positions and adding to 1,981 existing holdings. Its largest new stake was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, an estimated $213M trimmed.

  • Creative Planning's largest Q4 2024 buy was VanEck IG Floating Rate ETF: 1,040,413 shares worth $26.5M.
  • Creative Planning added most to Vanguard Total Bond Market in Q4 2024, an estimated $649M increase.
  • Creative Planning's biggest Q4 2024 reduction was WisdomTree Emerging Markets SmallCap Dividend Fund, cutting an estimated $213M.
  • Creative Planning fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $4.5M.
  • Creative Planning's ten largest holdings make up 46% of its $103B portfolio in Q4 2024.
  • Creative Planning opened 534 new positions and closed 136 in Q4 2024.
  • Creative Planning's portfolio value rose 1.8% quarter-over-quarter to $103B.

Based on Creative Planning's 13F filing for Q4 2024, filed 14 Feb 2025.